1,1,2,2-Tetrakis(4'-(pyridin-4-yl)-[1,1'-biphenyl]-4-yl)ethene, 97%, 1g

N-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine, 97%, 1g

(3aR,8aS)-2-(Pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 250mg

2-Bromo-6,7-dihydro-5H-cyclopenta[b]pyridin-5-one, 97%, 1g

Sertindole>95.0%(HPLC)50mg

Methyl Diphenylacetate>98.0%(GC)25g

8-Methylquinoline, 97.0%, 5g

2-(9H-Fluoren-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)25g

2�-Methylquinoxaline, 97.0%, 100g

2-Bromo-5-methylthiazole-4-carboxylic acid, 95.0%, 5g

1-(4-Bromophenyl)pentan-1-one, 95.0%, 500g

Methyl 2-bromo-5-sulfamoylbenzoate, 97%, 250mg

Pipetta per microlitro monocanale Proline® Plus variabile, da 0,5 a 10 µl, 1 pezzo